Flawed ivermectin preprint highlights challenges of COVID drug studies

Nature. 2021 Aug;596(7871):173-174. doi: 10.1038/d41586-021-02081-w.
No abstract available

Keywords: Public health; Publishing; Research data; SARS-CoV-2.

Publication types

  • News

MeSH terms

  • Antiparasitic Agents / therapeutic use
  • COVID-19 / mortality*
  • COVID-19 Drug Treatment*
  • Clinical Trials as Topic* / ethics
  • Clinical Trials as Topic* / standards
  • Humans
  • Ivermectin / therapeutic use*
  • Pandemics
  • Plagiarism
  • Preprints as Topic* / ethics
  • Preprints as Topic* / standards
  • Research Personnel / ethics
  • Research Personnel / standards
  • Retraction of Publication as Topic*
  • Sample Size
  • Scientific Misconduct / legislation & jurisprudence
  • World Health Organization

Substances

  • Antiparasitic Agents
  • Ivermectin